Rhodes Pharmaceuticals L.P.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Rhodes Pharmaceuticals L.P..The latest application filed is for "tamper resistant immediate release formulations".
- Rhodes Pharmaceuticals L.P. - Coventry RI US
- Rhodes Pharmaceuticals, LP - Coventry RI US
Trademarks
| Patent | Date |
|---|---|
| Tamper Resistant Immediate Release Formulations App 20220031693 - Adjei; Akwete L. ; et al. | 2022-02-03 |
| Treatment For Dry Eye App 20210008079 - CONNOR; Charles Gerald ; et al. | 2021-01-14 |
| Pharmaceutical Resinate Compositions And Methods Of Making And Using Thereof App 20200253956 - Kind Code | 2020-08-13 |
| Controlled release formulations Grant 10,463,624 - Krishnamurthy , et al. No | 2019-11-05 |
| Pharmaceutical Resinate Compositions And Methods Of Making And Using Thereof App 20190262334 - Frunzi; Gerard P. ; et al. | 2019-08-29 |
| Buprenorphine-wafer for drug substitution therapy App 20190216797 - Oksche; Alexander ; et al. | 2019-07-18 |
| Methods of treating attention deficit hyperactivity disorder Grant 10,039,719 - Krishnamurthy , et al. August 7, 2 | 2018-08-07 |
| Methods of preparing oral controlled release formulations Grant 10,022,330 - Krishnamurthy , et al. July 17, 2 | 2018-07-17 |
| Methods of treating attention deficit hyperactivity disorder Grant 9,949,931 - Krishnamurthy , et al. April 24, 2 | 2018-04-24 |
| Methods of treating attention deficit hyperactivity disorder App 20180042854 - Krishnamurthy; Thinnayam N. ; et al. | 2018-02-15 |
| Controlled Release Formulations App 20180008544 - Krishnamurthy; Thinnayam N. ; et al. | 2018-01-11 |
| Buprenorphine Wafer For Drug Substitution Therapy App 20180008595 - OKSCHE; Alexander ; et al. | 2018-01-11 |
| Buprenorphine-wafer for drug substitution therapy Grant 9,861,628 - Oksche , et al. January 9, 2 | 2018-01-09 |
| Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations Grant 9,801,823 - Krishnamurthy , et al. October 31, 2 | 2017-10-31 |
| Methods For Treating Attention Deficit Hyperactivity Disorder With Methylphenidate App 20170196846 - Adjei; Akwete L. | 2017-07-13 |
| Controlled Release Formulations Having Rapid Onset And Rapid Decline Of Effective Plasma Drug Concentrations App 20170135999 - Krishnamurthy; Thinnayam N. ; et al. | 2017-05-18 |
| Methods Of Preparing Oral Controlled Release Formulations App 20170079921 - Krishnamurthy; Thinnayam N. ; et al. | 2017-03-23 |
| Methods Of Treating Attention Deficit Hyperactivity Disorder App 20170071926 - Krishnamurthy; Thinnayam N. ; et al. | 2017-03-16 |
| Treatment for dry eye App 20140113889 - Connor; Charles Gerald ; et al. | 2014-04-24 |
| NCAGE Code | 5ZQZ5 | RHODES PHARMACEUTICALS L.P. |
| CAGE Code | 5ZQZ5 | RHODES PHARMACEUTICALS L.P. |
| S.A.M. Registration | 5ZQZ5 [831928986] | RHODES PHARMACEUTICALS L.P. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 